Swiss National Bank’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q4
Sell
-2,329,024
Closed -$231M 2601
2019
Q3
$231M Buy
2,329,024
+40,128
+2% +$3.81M 0.25% 83
2019
Q2
$212M Sell
2,288,896
-45,100
-2% -$4.28M 0.23% 87
2019
Q1
$220M Buy
2,333,996
+47,400
+2% +$4.15M 0.24% 85
2018
Q4
$147M Sell
2,286,596
-27,200
-1% -$2.01M 0.19% 109
2018
Q3
$207M Sell
2,313,796
-173,100
-7% -$15.3M 0.23% 86
2018
Q2
$198M Sell
2,486,896
-39,100
-2% -$3.25M 0.23% 92
2018
Q1
$225M Sell
2,525,996
-359,700
-12% -$34.5M 0.27% 74
2017
Q4
$301M Buy
2,885,696
+7,100
+0.2% +$801K 0.33% 62
2017
Q3
$420M Buy
2,878,596
+36,000
+1% +$4.9M 0.48% 38
2017
Q2
$369M Buy
2,842,596
+95,700
+3% +$11.7M 0.44% 37
2017
Q1
$342M Buy
2,746,896
+588,000
+27% +$70.4M 0.43% 38
2016
Q4
$250M Buy
2,158,896
+7,700
+0.4% +$858K 0.39% 45
2016
Q3
$225M Sell
2,151,196
-39,800
-2% -$4.31M 0.36% 53
2016
Q2
$216M Buy
2,190,996
+149,800
+7% +$15.5M 0.35% 57
2016
Q1
$196M Buy
2,041,196
+605,200
+42% +$62.3M 0.36% 54
2015
Q4
$172M Buy
1,435,996
+20,700
+1% +$2.39M 0.42% 42
2015
Q3
$153M Buy
1,415,296
+123,500
+10% +$15.3M 0.39% 50
2015
Q2
$150M Buy
1,291,796
+75,000
+6% +$8.57M 0.39% 53
2015
Q1
$140M Buy
1,216,796
+473,400
+64% +$56.6M 0.37% 54
2014
Q4
$83.2M Sell
743,396
-27,600
-4% -$2.91M 0.31% 73
2014
Q3
$73.1M Sell
770,996
-20,400
-3% -$1.84M 0.28% 76
2014
Q2
$68M Sell
791,396
-7,400
-0.9% -$563K 0.25% 88
2014
Q1
$55.8M Sell
798,796
-77,600
-9% -$6.15M 0.22% 110
2013
Q4
$74M Sell
876,396
-27,000
-3% -$2.14M 0.29% 78
2013
Q3
$69.5M Buy
903,396
+12,000
+1% +$841K 0.29% 77
2013
Q2
$52.1M Buy
+891,396
New +$53.6M 0.23% 109

Other funds holding CELG

Swiss National Bank's CELG Position: Q4 2019 in Review

Swiss National Bank sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 2,329,024 shares — an estimated $231M sold.

Swiss National Bank first reported a position in CELG in Q2 2013 and held it in 26 quarters. The position peaked at $420M in Q3 2017. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Swiss National Bank reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Swiss National Bank sold 2,329,024 Celgene Corp shares in Q4 2019, an estimated $231M.
  • Swiss National Bank first reported a position in Celgene Corp in Q2 2013 and held it in 26 quarters.
  • Swiss National Bank's Celgene Corp position peaked at $420M in Q3 2017.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Swiss National Bank's 13F filing for Q4 2019, filed 6 Feb 2020.